博文
2024年妇科恶性肿瘤抗体偶联药物临床应用指南发布
||
2024年妇科恶性肿瘤抗体偶联药物临床应用指南发布
https://wap.sciencenet.cn/blog-280034-1447305.html
上一篇：江南水乡
下一篇：沙库巴曲缬沙坦治疗高血压及并发症
https://mp.weixin.qq.com/s/ffg9dRUi6qWneplk1sFwlg
(74)
(20)
(15)
(13)
(9)
(9)
(8)
(8)
(7)
(6)
http://www.pubmedplus.cn/P/SearchQuickResult?wd=89cf1e0f-491e-4617-922a-4c135540468e
| 01. | Antibodies, Monoclonal | 223 篇 | 100.000% |
| 02. | Immunoconjugates | 223 篇 | 100.000% |
| 03. | Neoplasms | 223 篇 | 100.000% |
| 04. | Humans | 218 篇 | 97.758% |
| 05. | Antineoplastic Agents | 132 篇 | 59.193% |
| 06. | Animals | 114 篇 | 51.121% |
| 07. | Mice | 47 篇 | 21.076% |
| 08. | Cell Line, Tumor | 32 篇 | 14.350% |
| 09. | Drug Delivery Systems | 30 篇 | 13.453% |
| 10. | Molecular Targeted Therapy | 29 篇 | 13.004% |
https://wap.sciencenet.cn/blog-280034-1447305.html
上一篇：江南水乡
下一篇：沙库巴曲缬沙坦治疗高血压及并发症
